Results 71 to 80 of about 25,955 (297)
Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler +20 more
wiley +1 more source
THE EFFECTIVENESS OF ENVIRONMENTAL IMPACT ASSESSMENT SYSTEMS IN SÃO PAULO AND MINAS GERAIS STATES [PDF]
Ambiente & Sociedade, 2017 The effectiveness of the Environmental Impact Assessment (EIA) has been analyzed through the application of good practice criteria, with emphasis on assessing the quality of studies involved in it.
MARIA RITA RAIMUNDO E ALMEIDA +1 more
doaj +3 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi +9 more
wiley +1 more source
Desenvolvimento em Questão, 2017 This paper addresses the social and environmental conflicts in a protected landscape of sustainable use which has faced urban expansion of high social exclusion.
José Maria Bernardelli Junior +2 more
doaj
THE NEW ENVIRONMENTAL LICENSING IN BRASIL
Federal Law No. 6,938/198, the Environmental Impact Assessment (EIA), and the Environmental Impact Report (RIMA) are fundamental Brazilian landmarks that provide for environmental licensing as a strategy to ensure prevention through precaution, social participation, and ecological balance.
Alves, Daniela +4 more
openaire +2 more sources
R&D Portfolios and Pharmaceutical Licensing [PDF]
We examine how R&D portfolios of drug pipelines affect pharmaceutical licensing, controlling firm size, diversity, and competitors in R&D and product markets.
Junichi Nishimura, Yosuke Okada
core
Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source
Licenciamentos ambientais de grandes empreendimentos: tendência à judicialização?
Desenvolvimento e Meio Ambiente, 2018 Environmental licensing processes in Brazil have received increasing attention from the media and the public, particularly those that involve large projects of infrastructure, a range of actors and diverse interests (i.e. port sector).
Victor Caldas Ferreira de Carvalho +1 more
doaj +1 more source
Environmental Standards under International Oligopoly [PDF]
We explore the effects of domestic environmental standards when a domestic firm and a foreign rival compete in the domestic market. We focus on a situation where the introduction of environmental standards forces the foreign product out of the domestic ...
ISHIKAWA Jota, OKUBO Toshihiro
core
, 2022 The Access to Information Law nº 12.527/2011, has publicity as its general principle, and data confidentiality becomes an exception, thus ensuring that non-confidential information produced by the Public Power must be made available to citizens ...
Lima, Rafaela Silva de Oliveira de
core